Create account

Coverage dated October 5, 2026 to October 6, 2026

STAT+: AstraZeneca opens new Boston site

Headline from STAT

AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.

STAT's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

4 articles, oldest first.

  1. Quartz

    AstraZeneca opens $1 billion R&D center in Kendall Square (opens Quartz)

    Published

    Quartz's feed description

    The 570,000-square-foot facility will house nearly 2,000 researchers and expand AstraZeneca's Massachusetts workforce by over 50%

  2. The Boston Globe

    Robot researchers: AstraZeneca opens $1 billion research center in Kendall Square (opens The Boston Globe)

    Published

    The Boston Globe's feed description

    The investment is expected to increase the pharma giant's workforce in Massachusetts to 3,000 employees within a few years.

  3. Boston

    What to know about AstraZeneca’s tremendous new R&D center in Kendall Square (opens Boston)

    Published

    Boston's feed description

    The biopharmaceutical company plans to expand its Massachusetts workforce by over 50% as the industry faces broader headwinds.

  4. STAT

    STAT+: AstraZeneca opens new Boston site (opens STAT)

    Published

    STAT's feed description

    AstraZeneca opened a new R&D site in Kendall Square yesterday, celebrating a $1 billion investment in the unsettled center of U.S. biotechnology after a spate of Chinese dealmaking.

STAT+: AstraZeneca opens new Boston site | Since Then